Consensus Silk Road Medical, Inc

Equities

SILK

US82710M1009

Real-time Estimate Cboe BZX Other stock markets 11:43:32 2024-04-30 am EDT			5-day change	1st Jan Change
19.36 ^USD	+2.41%		+10.64%	+59.33%

Apr. 02	Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuro Protection System Plus	CI
Mar. 08	North American Morning Briefing : Stock Futures -2-	DJ

Evolution of the average Target Price on Silk Road Medical, Inc

Price target over the last 5 years

History of analyst recommendation changes

1349540fb4a158.7dst8ZXEP4yZBkr5ie21-8Mo6Fny6iDUYMyiJpt8HWU.v5UUpPOcftvLPiSmxJfMoq1-3QHLphDtP5r3cP42VwC7mFii9I5J-M1OEw~54baec246b631379f36718f2239612e1

Analyst Recommendations on Silk Road Medical, Inc

Argus Upgrades Silk Road Medical to Buy From Hold, Price Target is $24	Mar. 07	MT
Piper Sandler Raises Price Target on Silk Road Medical to $18 From $11, Maintains Neutral Rating	Feb. 29	MT
Stifel Upgrades Silk Road Medical to Buy From Hold, Raises Price Target to $20 From $9	Jan. 19	MT
Lake Street Initiates Silk Road Medical at Buy Rating With $20 Price Target	Jan. 03	MT
Oppenheimer Adjusts Silk Road Medical Price Target to $25 From $30, Maintains Outperform Rating	Nov. 09	MT
Wolfe Research Upgrades Silk Road Medical to Peer Perform From Underperform	23-10-24	MT
BofA Lowers Price Target on Silk Road Medical to $8 From $28, Keeps Underperform Rating	23-10-18	MT
Piper Sandler Lowers Price Target on Silk Road Medical to $11 From $25, Maintains Neutral Rating	23-10-11	MT
B. Riley Downgrades Silk Road Medical to Neutral From Buy, Lowers Price Target to $14 From $54	23-10-11	MT
CL King Downgrades Silk Road Medical to Neutral From Buy	23-10-11	MT
Nephron Research Downgrades Silk Road Medical to Hold From Buy, Adjusts Price Target to $10 From $37	23-10-11	MT
Citigroup Downgrades Silk Road Medical to Sell From Buy, Cuts Price Target to $8 From $35	23-10-11	MT
Stifel Downgrades Silk Road Medical to Hold From Buy, Cuts Price Target to $12 From $45	23-10-11	MT
Argus Research Downgrades Silk Road Medical to Hold From Buy	23-09-21	MT
Oppenheimer Initiates Coverage on Silk Road Medical With Outperform Rating, $30 Price Target	23-09-06	MT
Citigroup Cuts Price Target on Silk Road Medical to $35 From $48, Maintains Buy Rating	23-08-14	MT
Stifel Adjusts Price Target on Silk Road Medical to $45 From $50, Maintains Buy Rating	23-08-02	MT
B. Riley Lowers Silk Road Medical's PT to $54 From $58, Keeps Buy Rating	23-08-02	MT
BofA Securities Downgrades Silk Road Medical to Underperform From Buy, Adjusts Price Target to $28 From $51	23-07-12	MT
JPMorgan Downgrades Silk Road Medical to Neutral From Overweight, Cuts Price Target to $28 From $50	23-07-12	MT
CL King Initiates Silk Road Medical at Buy With $47 Price Target	23-05-23	MT
Argus Adjusts Silk Road Medical's Price Target to $55 From $70, Keeps Buy Rating	23-05-22	MT
Wolfe Research Downgrades Silk Road Medical to Underperform From Peer Perform, Price Target is $27	23-05-15	MT
Citigroup Adjusts Silk Road Medical's Price Target to $48 From $50, Keeps Buy Rating	23-05-10	MT
Piper Sandler Adjusts Price Target on Silk Road Medical to $41 From $46, Keeps Neutral Rating	23-05-10	MT